HPV-Vaccines
Human papillomavirus (HPV) is closely linked with the pathogenesis of cervical cancer and many other cancers. HPV vaccines are vaccines that prevent infection from certain types of human papillomavirus. However, despite the various prevention strategies and treatments, such as HPV screening, prophyl...
Kaydedildi:
| Materyal Türü: | Online |
|---|---|
| Dil: | İngilizce |
| Baskı/Yayın Bilgisi: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Konular: | |
| Online Erişim: | ONIX_20230714_9783036559179_92 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
| _version_ | 1869524126569332736 |
|---|---|
| collection | Directory of Open Access Books |
| description | Human papillomavirus (HPV) is closely linked with the pathogenesis of cervical cancer and many other cancers. HPV vaccines are vaccines that prevent infection from certain types of human papillomavirus. However, despite the various prevention strategies and treatments, such as HPV screening, prophylactic HPV vaccines, surgery, radiotherapy, and chemotherapy, the disease burden remains heavy worldwide. Currently, three types of prophylactic vaccines—quadrivalent HPV vaccines, bivalent HPV vaccines, and a new nonavalent HPV vaccine—are commercially available. Although these vaccines protect against 90% of HPV infections, their capacity to eliminate pre-existing infections is limited. In this Topical Collection, we aim to systematically cover the progress, current status, and future prospects of various vaccines being developed for the prevention and treatment of HPV-associated lesions and cancers. |
| format | Online |
| id | doab-20.500.12854ir-101393 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1013932024-03-31T13:10:34Z HPV-Vaccines Calagna, Gloria HPV HPV vaccine social media mobile phone HPV vaccine intervention RE-AIM Framework human papillomavirus vaccination coverage recipient-oriented interventions provider-oriented interventions systematic review human papillomavirus vaccination adverse effects orthostatic dysregulation chronic regional pain syndrome cognitive dysfunction HPV vaccination men who have sex with men online health promotion outcome and process evaluation Human Papillomavirus barriers pharmacists vaccination cervical cancer cervical intraepithelial neoplasia E6 oncoprotein E7 oncoprotein therapeutic vaccine DNA vaccine DNA therapeutic vaccine pharmacy vaccine referral family medicine obstetrics and gynecology HPV vaccine barriers provider perspectives vaccines AEFIs causality assessment dosing schedule dosing interval 9-valent low adherence HPV serum antibodies L1 HPV 9-valent vaccination squamous intraepithelial neoplasia HPV vaccine knowledge HPV vaccine awareness Kazakhstan cervical cancer prevention human papilloma virus health behaviour vaccine hesitancy membranous nephropathy p16 INK4a mass spectrometry vaccine effectiveness vaccine impact real-world evidence systematic literature review thema EDItEUR::M Medicine and Nursing Human papillomavirus (HPV) is closely linked with the pathogenesis of cervical cancer and many other cancers. HPV vaccines are vaccines that prevent infection from certain types of human papillomavirus. However, despite the various prevention strategies and treatments, such as HPV screening, prophylactic HPV vaccines, surgery, radiotherapy, and chemotherapy, the disease burden remains heavy worldwide. Currently, three types of prophylactic vaccines—quadrivalent HPV vaccines, bivalent HPV vaccines, and a new nonavalent HPV vaccine—are commercially available. Although these vaccines protect against 90% of HPV infections, their capacity to eliminate pre-existing infections is limited. In this Topical Collection, we aim to systematically cover the progress, current status, and future prospects of various vaccines being developed for the prevention and treatment of HPV-associated lesions and cancers. 2023-07-14T14:29:29Z 2023-07-14T14:29:29Z 2023 book ONIX_20230714_9783036559179_92 9783036559179 9783036559186 https://directory.doabooks.org/handle/20.500.12854/101393 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/7490 https://mdpi.com/books/pdfview/book/7490 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-5918-6 10.3390/books978-3-0365-5918-6 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036559179 9783036559186 214 Basel open access |
| spellingShingle | HPV HPV vaccine social media mobile phone HPV vaccine intervention RE-AIM Framework human papillomavirus vaccination coverage recipient-oriented interventions provider-oriented interventions systematic review human papillomavirus vaccination adverse effects orthostatic dysregulation chronic regional pain syndrome cognitive dysfunction HPV vaccination men who have sex with men online health promotion outcome and process evaluation Human Papillomavirus barriers pharmacists vaccination cervical cancer cervical intraepithelial neoplasia E6 oncoprotein E7 oncoprotein therapeutic vaccine DNA vaccine DNA therapeutic vaccine pharmacy vaccine referral family medicine obstetrics and gynecology HPV vaccine barriers provider perspectives vaccines AEFIs causality assessment dosing schedule dosing interval 9-valent low adherence HPV serum antibodies L1 HPV 9-valent vaccination squamous intraepithelial neoplasia HPV vaccine knowledge HPV vaccine awareness Kazakhstan cervical cancer prevention human papilloma virus health behaviour vaccine hesitancy membranous nephropathy p16 INK4a mass spectrometry vaccine effectiveness vaccine impact real-world evidence systematic literature review thema EDItEUR::M Medicine and Nursing HPV-Vaccines |
| title | HPV-Vaccines |
| title_full | HPV-Vaccines |
| title_fullStr | HPV-Vaccines |
| title_full_unstemmed | HPV-Vaccines |
| title_short | HPV-Vaccines |
| title_sort | hpv vaccines |
| topic | HPV HPV vaccine social media mobile phone HPV vaccine intervention RE-AIM Framework human papillomavirus vaccination coverage recipient-oriented interventions provider-oriented interventions systematic review human papillomavirus vaccination adverse effects orthostatic dysregulation chronic regional pain syndrome cognitive dysfunction HPV vaccination men who have sex with men online health promotion outcome and process evaluation Human Papillomavirus barriers pharmacists vaccination cervical cancer cervical intraepithelial neoplasia E6 oncoprotein E7 oncoprotein therapeutic vaccine DNA vaccine DNA therapeutic vaccine pharmacy vaccine referral family medicine obstetrics and gynecology HPV vaccine barriers provider perspectives vaccines AEFIs causality assessment dosing schedule dosing interval 9-valent low adherence HPV serum antibodies L1 HPV 9-valent vaccination squamous intraepithelial neoplasia HPV vaccine knowledge HPV vaccine awareness Kazakhstan cervical cancer prevention human papilloma virus health behaviour vaccine hesitancy membranous nephropathy p16 INK4a mass spectrometry vaccine effectiveness vaccine impact real-world evidence systematic literature review thema EDItEUR::M Medicine and Nursing |
| topic_facet | HPV HPV vaccine social media mobile phone HPV vaccine intervention RE-AIM Framework human papillomavirus vaccination coverage recipient-oriented interventions provider-oriented interventions systematic review human papillomavirus vaccination adverse effects orthostatic dysregulation chronic regional pain syndrome cognitive dysfunction HPV vaccination men who have sex with men online health promotion outcome and process evaluation Human Papillomavirus barriers pharmacists vaccination cervical cancer cervical intraepithelial neoplasia E6 oncoprotein E7 oncoprotein therapeutic vaccine DNA vaccine DNA therapeutic vaccine pharmacy vaccine referral family medicine obstetrics and gynecology HPV vaccine barriers provider perspectives vaccines AEFIs causality assessment dosing schedule dosing interval 9-valent low adherence HPV serum antibodies L1 HPV 9-valent vaccination squamous intraepithelial neoplasia HPV vaccine knowledge HPV vaccine awareness Kazakhstan cervical cancer prevention human papilloma virus health behaviour vaccine hesitancy membranous nephropathy p16 INK4a mass spectrometry vaccine effectiveness vaccine impact real-world evidence systematic literature review thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20230714_9783036559179_92 |